Quick infos Headquarters: Woburn, Massachusetts, United States Trade prices Volume: Market Cap: 663.77M Prev closed: 23.09 Open: 23.58 High: 25.16 Low: 23.32 52 week low: 8.58 52 week high: 25.16 Dividends: Next ER: May 26, 2022 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast August 5, 2022 May 19, 2022 -0.6071 / -0.5938- / -February 3, 2022 -0.57 / -0.5513- / -November 4, 2021 -0.56 / -0.5133- / -August 6, 2021 -0.53 / -0.4411- / -view more
Historical Data Date Price Open High Low Vol Change ER May 26, 2022 14.12 13.94 14.46
13.94
164.13K 1.58% May 25, 2022 13.90 14.16 14.44
13.54
391.62K -1.7% May 24, 2022 14.14 14.35 14.55
13.67
333.02K -0.56% May 23, 2022 14.22 14.96 14.96
14.12
259.57K -3.85% May 20, 2022 14.79 14.49 15.01
14.12
251.69K 2.85% May 19, 2022 14.38 13.97 14.72
13.47
376.99K 1.05% May 18, 2022 14.23 15.00 15.47
14.17
273.17K -8.13% May 17, 2022 15.49 15.01 15.59
14.84
521.70K 6.61% May 16, 2022 14.53 14.61 14.89
14.04
287.91K -2.02% May 13, 2022 14.83 14.46 15.17
14.25
248.85K 5.48% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2015 Employees:122 News
Replimune Announces Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting finance.yahoo.com Oct 14, 2020 12:29 pm
Is Replimune Group, Inc. (REPL) A Good Stock To Buy? finance.yahoo.com Aug 12, 2020 2:19 pm Replimune files for $350M mixed shelf seekingalpha.com Aug 12, 2020 4:55 am Replimune Group EPS beats by $0.01 seekingalpha.com Aug 7, 2020 7:12 pm
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update finance.yahoo.com Aug 7, 2020 7:00 am
Replimune to Present at Two Upcoming Investor Conferences finance.yahoo.com Aug 4, 2020 7:00 am
Replimune Appoints Andrea Pirzkall, M.D. as Chief Medical Officer finance.yahoo.com Jul 22, 2020 7:00 am Replimune prices $100M share-offering seekingalpha.com Jun 9, 2020 4:50 pm
Stocks That Hit 52-Week Highs On Monday benzinga.com Jun 8, 2020 11:05 pm BRIEF-Replimune Group Entered Into Amendment No. 1 To Sales Agreement reuters.com Jun 8, 2020 8:06 pm BRIEF-Replimune Announces Proposed Public Offering reuters.com Jun 8, 2020 8:06 pm BRIEF-Replimune Reports Fiscal Q4 And Full Year 2020 Results reuters.com Jun 3, 2020 10:06 pm Replimune Provides RP1 Data Update from its Phase 2 Cohorts in Melanoma and Non-Melanoma Skin Cancer that Strongly Support Replimune's Ongoing Registration-Directed Clinical Trials with RP1 finance.yahoo.com Jun 3, 2020 7:06 am Replimune to Provide Data Update on June 3, 2020 finance.yahoo.com Apr 30, 2020 7:04 am Replimune Appoints Dieter Weinand as Chairman and Paolo Pucci to the Board of Directors finance.yahoo.com Apr 2, 2020 7:04 am
Replimune Announces Proposed Public Offering finance.yahoo.com Jul 1, 2020 4:16 pm
Replimune Reports Financial Results for the Second Fiscal Quarter, Ended September 30, and Provides Development and Corporate Update finance.yahoo.com Jul 1, 2020 8:00 am
Replimune Group, Inc. (REPL): Hedge Funds Are Reducing Exposure finance.yahoo.com Jun 22, 2020 2:27 pm
Replimune to Participate at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference finance.yahoo.com Jun 17, 2020 8:00 am Talk about Replimune Group below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet